Beckman Coulter Life Sciences announced a strategic partnership with lab‑automation firm Automata to integrate liquid‑handling and genomics instruments into Automata’s LINQ automation ecosystem; Danaher Ventures joined Automata’s Series C financing and the Automata board. The collaboration aims to deliver modular, AI‑ready automation workcells and improve reliability and data integrity for high‑throughput wet‑lab workflows. Danaher’s strategic investment—part of a roughly $45 million Series C—signals industrial endorsement of automation stacks that underpin AI‑driven discovery and closed‑loop experimentation.